Medical device market in 2030: Ophthalmic device manufacturing

Medical Infographic

Medical device market in 2030: Ophthalmic device manufacturing

"Medical devices 2030: Making a power play to avoid the commodity trap," predicts a 5.2% compound annual growth rate (CAGR) for medical devices throughout the next 12 years.

Editor’s note: Part 1 of 3.

KPMG’s study, “Medical devices 2030: Making a power play to avoid the commodity trap,” predicts a 5.2% compound annual growth rate (CAGR) for medical devices throughout the next 12 years and stresses the need for manufacturers to lower the cost of health care delivery. Within the report are several predictions about how developing technologies will impact ophthalmological care. Future infographics will examine the future of cardiovascular and orthopedic care.

5 Years

Artificial intelligence

Miniature retinal scanners

Virtual reality devices

10 years

Autonomous surgical robots/robotic eye surgery

Implantable bionic lenses

Smart contact lenses

Contact lens/eyeglass combinations

15 years

Eye-imaging visual systems

Nanodiamond-based drug-delivery systems

Advanced bionic eyes

Incumbents need to consider their positions in the 2030 medical device value chain, to avoid becoming commodity providers. Even the strongest and largest players are vulnerable to disruptive entrants, global competition, and technological leaps. With a firm focus on the value they bring to future health systems, medical device manufacturers need to consider brave, but essential power plays to reconfigure their value chain. — KPMG